VistaGen Therapeutics Inc (VTGN) — Cash Flow Reinvestment Rate
Latest as of September 2020:
0.20x
VistaGen Therapeutics Inc (VTGN) has a Cash Flow Reinvestment Rate of 0.20x as of September 2020, reinvesting $197.60K (capex $98.80K plus investments $-98.80K) from operating cash flow of $1.00 Million. See VTGN free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.20x
(Capex + Investments) / Operating CF
Total Reinvested
$197.60K
Capex + Investments
Operating Cash Flow
$1.00 Million
USD
Capital Expenditures
$98.80K
USD
Annual Cash Flow Reinvestment Rate for VistaGen Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for VistaGen Therapeutics Inc. See how financially flexible is VistaGen Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow